Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology intomachine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification.It was founded in 2020 and headquartered in New York, United States.

Biotechnology

Therapeutics

Nine Square Therapeutics

Nine Square Therapeutics' headquarters in New York, NY, United States

Steve Altschuler

Description

People

Jobs